Skip to content

Clinical trials

Neoplasm Metastasis trials in Estonia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Estonia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20072
20081
20111
20142
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Approved for marketing1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
AbbVie1
Bavarian Nordic1
Celgene1
GlaxoSmithKline1
Halozyme Therapeutics1
Institut de Recherches Internationales Servier1
Mologen AG1
Novartis1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis11
Colorectal Neoplasms3
Neoplasms3
Prostatic Neoplasms2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Pancreatic Ductal1
Carcinoma, Renal Cell1
Esophageal Neoplasms1
Melanoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.